Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Inventory (2019 - 2025)

Marimed (MRMD) has disclosed Change in Inventory for 7 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 68.33% to $1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 86.57% decrease, with the full-year FY2024 number at $8.2 million, up 40.37% from a year prior.
  • Change in Inventory was $1.2 million for Q3 2025 at Marimed, down from $1.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $3.8 million in Q3 2024 to a low of -$1.5 million in Q4 2024.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2025 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: plummeted 4435.22% in 2021, then skyrocketed 760.24% in 2024.
  • Marimed's Change in Inventory stood at -$1.2 million in 2021, then skyrocketed by 195.27% to $1.2 million in 2022, then decreased by 5.74% to $1.1 million in 2023, then tumbled by 235.06% to -$1.5 million in 2024, then surged by 181.71% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Change in Inventory are $1.2 million (Q3 2025), $1.3 million (Q2 2025), and $453000.0 (Q1 2025).